Clover Health Investments (CLOV) says SEC concluded its investigation

Clover Health Investments (NASDAQ: CLOV) disclosed"

By letter dated September 26, 2024 (the “Notice”), the Staff of the Securities and Exchange Commission's (the "SEC") Division of Enforcement notified Clover Health Investments, Corp. (the “Company”) that the SEC had concluded its investigation of the Company commenced in February 2021 (the "Investigation"), and based on the information that the SEC had as of the date of the Notice, the Staff did not intend to recommend an enforcement action by the SEC against the Company relating to the Investigation. The Notice was provided under the guidelines set forth in the final paragraph of Securities Act Release No. 5310.

The Investigation was previously disclosed by the Company in its periodic reports under the Securities Exchange Act of 1934, as amended. Additional information regarding the Investigation can be found in the Company’s prior filings, including the Company’s Form 10-Q for the quarterly period ended June 30, 2024, filed with the SEC on August 8, 2024.

You May Also Be Interested In

• Rio Tinto plc (RIO) to acquire Arcadium Lithium
• Biglari Capital Issues Letter to Shareholders of Cracker Barrel (CBRL)
• Asbury Automotive Group (ABG) Sues to Block Administrative Proceeding by the FTC